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Poster #1
WNT signals are required for the initiation of hair follicle development and for
postnatal hair growth. Thomas Andl1, Seshamma Reddy1, Adam Glick2 and Sarah E. Millar1, 1De-
partments of Dermatology and Cellular and Developmental Biology, University of Pennsylvania,
Philadelphia, PA and 2Laboratory of Cellular Carcinogenesis and Tumor Promotion, N. C. I.,
Bethesda, MD.
Mutations in downstream e¡ector genes of a conserved WNT signaling pathway cause hair follicle
phenotypes, suggesting that WNTproteins control hair follicle development and postnatal hair folli-
cle cycling. To begin to test this hypothesis we surveyed forWnt andWNT receptor (Frizzled) gene
expression in developing and postnatal mouse skin.We discovered that severalWnt and Frizzled genes
are expressed in developing hair follicles, in speci¢c cell layers of postnatal anagen follicles, and in the
dermal papilla and adjacent epithelial cells of hair follicles at anagen onset. To investigate the e¡ects of
blocking the actions of WNT proteins in the skin and hair we made use of Dickkopf 1 (DKK1), a
potent secretedWNT inhibitor. Transgenic embryos expressing high levels of Dkk1 in basal epidermal
cells under the control of a keratin 14 promoter displayed a complete absence of hair follicle, tooth and
mammary gland development. Molecular markers of hair follicle placodes, including the very early
markers Ectodysplasin receptor and Lef1, failed to show normal patterned expression in transgenic
skin, indicating that WNT signals are required for the localized expression of placode markers and
for initiation of hair follicle development. To determine whether WNT signals are also necessary for
postnatal hair follicle cycling we developed a bi-transgenic system in which expression of Dkk1 in the
epidermis and hair follicle outer root sheath can be induced by oral doxycycline. Doxycycline treat-
ment of embryos throughout gestation caused phenotypes identical to those resulting from constitu-
tive expression of Dkk1. In contrast, single transgenic and untreated bi-transgenic pups were normal.
Administration of doxycycline to previously untreated bi-transgenic postnatal mice prevented hair
growth. WNT signals are therefore necessary for both hair follicle formation and postnatal hair
growth.
Poster #2
Decreased serum ferritin is associated with alopecia areata in women. Jonathan Kan-
tor1, Lisa Jay Kessler2, David Brooks2, George Cotsarelis3. Department of Biostatistics and Epidemiol-
ogy1, Division of Medical Genetics2 and Department of Dermatology3 University of Pennsylvania
School of Medicine, Philadelphia, Pennsylvania.
Our aim was to evaluate whether alopecia areata and alopecia areata totalis/universalis are associated
with decreased tissue iron stores (as measured by serum ferritin). Cases were obtained by selecting 18
consecutive patients over the age of 18 treated at the University of Pennsylvania hair and scalp clinic in
the years 2000 and 2001. Normal patients were obtained by sampling individuals screened negative in
the Hospital of the University of Pennsylvania Division of Medical Genetics for the HFE-1 genotype
for hemochromatosis. Using the t-test, we found that the mean ferritin level (stated as ng/ml [95%
con¢dence intervals]) in cases with alopecia areata (25 [17, 33]) was statistically signi¢cantly lower than
levels in normal controls (61 [38, 84]), with a p-value of 0.0036. The mean ferritin level for patients
with alopecia areata totalis/universalis (n¼ 7) was 54 ([25, 94]) and not signi¢cantly di¡erent than the
normals (p¼ 0.32). Hemoglobin levels for patients with alopecia areata (13.0 [12.2, 13.7]) were also sta-
tistically signi¢cantly lower than normals (14 [13.4, 14.6]) with a p-value of 0.012, whereas hemoglobin
levels in patients with alopecia areata totalis/universalis were not statistically di¡erent than normals (p-
value¼ 0.12). To address the question of whether the alopecia patients were signi¢cantly younger than
the normals, we performed a one-sided t-test assuming unequal variances which resulted in a p-value
of 0.292, suggesting that any di¡erences in ferritin levels between cases and controls were not second-
ary to a younger patient population. This is the ¢rst study to utilize a case-control methodology to
address the relationship between iron levels and alopecia areata and alopecia areata totalis/univeralis.
Our ¢ndings suggest that low iron levels may lower the threshold for developing alopecia areata.
Future studies to determine whether iron replacement therapy alters the course of alopecia areata will
be necessary to evaluate its therapeutic potential.
Poster #3
Interleukin-10 knockout mice are relatively resistant to the experimental induction
of alopecia areata. Pia Freyschmidt-Paul1, Kevin McElwee1, Margot Z˛ller1, John Sundberg2,
Rudolf Happle1, Rolf Ho¡mann.1 Philipp University Marburg, Germany; DKFZ, Germany1; The
Jackson Laboratory, Bar Harbor, USA.2
Alopecia areata (AA) occurs spontaneously in C3H/HeJ mice, but it can be induced in una¡ected C3H/
HeJ mice or other histocompatible strains by grafting of AA-a¡ected mouse skin. Because IL-10 ex-
pression is increased in scalp from AA-patients, successfully treated with DCP, we wanted to determine
whether the absence of IL-10 results in increased susceptibility to the development of AA. For this
purpose we tried to induce AA in 20 C3H/HeJBir-Il10-/- mice by skin grafting and as controls we
grafted AA-a¡ected skin onto 20 una¡ected C3H/HeJ mice. FACS-analysis for a wide panel of cyto-
kines and surface markers was performed on skin-in¢ltrating leucocytes and cells from skin draining
lymph nodes. 13/20 IL-10-/- mice did not develop hair loss, 7/20 IL-10-/- mice developed limited AA,
but no mice developed extensive AA. In contrast, 19/20 controls developed AA. FACS-analysis revealed
elevated levels of dendritic cells and monocytes in the skin and of dendritic cells in lymph nodes of IL-
10-/- mice compared to controls, but a similar level of monocytes in lymph nodes of both groups. IL-
10-/- mice had increased levels of IFN-g and TNF-a in lymph nodes and decreased levels of IL-6 in
skin. CD25, CD28, CD40, CD80 and CD86 were increased in skin of IL-10-/- mice and CD44s,
CD44v3, CD44v6, CD44v7 and CD44v10 were increased in both, skin and lymph nodes of IL-10-/-
mice. In a second part of the study, skin from IL-10-/- mice and from C3H/HeJ mice without AAwas
grafted onto C3H/HeJ mice with extensive AA. AA developed in skin grafts from normal C3H/HeJ
mice, but not in skin grafts from IL-10-/- mice. Contrary to expectations we have found that IL-10
de¢cient mice are relatively resistant to the induction of AA, despite their elevated levels of proin£am-
matory cytokines and adhesion molecules.Whether the decreased levels of IL-6 could be responsible
for the resistance to AA induction requires further investigation.
Poster #4
A polymorphism of the autoimmune regulator (AIRE) gene with potential func-
tional signi¢cance is strongly associated with alopecia universalis. Rachid Tazi-Ahnini,
Michael J. Cork, David J. Gawkrodger, DaveWengraf, Andrew G. Messenger, Andrew J.G. McDonagh.
Dermatology Immunogenetics Group, Division of Genomic Medicine, University of She⁄eld, UK
Alopecia areata (AA) is a chronic in£ammatory disease characterised by patchy hair loss with T cell
in¢ltration of hair follicles. The lifetime risk of AA is approximately 1% in the general population,
but this is increased to 30% or more in the autoimmune polyendocrinopathy candidiasis ectodermal
dysplasia syndrome (APECED), a recessive disorder due to mutation of the autoimmune regulator
(AIRE) gene on chromosome 21q22.3.We have therefore studied the possible involvement of AIRE
in the pathogenesis of AA. On screening the AIRE coding sequence, we identi¢ed 22 variants. Two
variants at positions G961C and T1029C gave amino acid changes S278R and V301A located in the
DNA-binding segment (SAND) and PHD1 zinc ¢nger motif respectively.We have developed geno-
typing assays for both G961C andT1029C variants. TheAIRE T1029C variant was not informative and
the frequency of the rare allele (961C) of the AIRE G961C variant was 0.08 in our control group.We
developed di¡erential double enzyme assays to discriminate the AIRE G961C alleles and genotyped
202 AA patients and 175 matched Caucasian controls. There was a signi¢cant increase in the frequency
of the 961C allele in AA patients overall to 0.13. This increase was higher in severe disease (alopecia
universalis) 0.20.We found no association between theAIRE G961C variant and mild (patchy) AA or
alopecia totalis. However, the AIRE 961C allele presents a strong risk factor (more than three times)
for development of the most severe form of AA [(OR)¼ 3.27 (1.56,6.88) p¼ 0.0012]. This allele is also
a risk factor for disease of early age at onset (o30 yrs) [OR 2.22 (1.22,4.03) p¼ 0.0082]. The amino
acid change from serine to arginine in the SAND domain of AIRE may have a signi¢cant e¡ect on
Aire DNA-binding activity. Moreover, our results could provide a rational explanation of the unu-
sually high frequency of AA in APECED patients which also supports the concept of AA as an auto-
immune disease.
Poster #5
Thymosin b4 promotes wound repair and hair regeneration via an actin binding
sequence. D Philp, M Elkin, and HK Kleinman, Craniofacial Developmental Biology and Regen-
eration Branch, National Institutes of Dental and Craniofacial Research, NIH, Bethesda, MD, USA
Thymosin b4 (Tb4) is a 43-amino acid polypeptide that is an important mediator of cell migration
and di¡erentiation. It promotes in vitro and in vivo angiogenesis and accelerates dermal wound healing
in animal models. Using synthetic peptide fragments we found that the 7-amino acid peptide contain-
ing the actin-binding motif (T-3) of Tb4 polypeptide is essential for its angiogenic activity. Migration
assays with human umbilical vein endothelial cell (HUVEC) primary cultures and vessel sprouting
assays using chick aortic arches conclusively show that Tb4 and the T-3 display near identical activity
in the nanogram range.While studying accelerated dermal wound healing byTb4 or T-3, we found
that they also stimulate hair growth in rat and mouse models. Preliminary studies show that HU-
VECs and human foreskin ¢broblasts (HFFs) display increase in MMP-1, -2, and -9 expression when
exposed to nanogram quantities of Tb4. Immunohistochemical staining showed increased levels of
MMP-9 in Tb4-treated wounds. These results demonstrate that the actin-binding motif of Tb4 is an
essential site for angiogenic and hair regeneration activity. It is likely that the wound healing activity
of Tb4, in part, resides in its ability to increase protease activity. These studies provide insights into
the mechanism of Tb4 activity in wound repair.
Poster #6
The histopathology of alopecia areata: a new look. D. A.Whiting-Baylor Hair Research
and Treatment
Purpose: Establish the evolving histopathology of alopecia areata, using follicular counts to relate
biopsy ¢ndings to the stage at which the patient presents. Methods: 4 mm punch biopsies were taken
from a scalp area of active, recent or old hair loss, or recent regrowth, in 50 consecutive new patients.
In horizontal sections, terminal anagen, catagen and telogen hairs, vellus or miniaturized hairs, folli-
cular units and follicular stelae (streamers) were counted; in£ammation and ¢brosis were rated as nil,
mild, moderate or dense. Anagen and telogen percentages and terminal to vellus hair ratios were cal-
culated. The duration of the current episode and total duration of alopecia areata were recorded. The
follicular counts and in£ammation ratings were correlated with patient sex, age, race, type of alopecia
areata, percentage hair loss, current duration, total duration and regression during current episode.
Follicular counts and in£ammation ratings from normal controls and patients with di¡use alopecia
were available for comparison. Results: A discernable pattern of the evolving histopathology was
found only by relating the biopsy ¢ndings to the duration of the current attack of alopecia areata; this
provided compelling data regarding the extent, site and timing of peribulbar lymphocytic in£amma-
tion and the changing anagen and telogen percentages and terminal to vellus ratios. These ¢ndings are
summarized according to the stage of the disease: Acute stage: Bulbar lymphocytes involve terminal
hairs in early episodes and miniaturized hairs in repeated episodes. Subacute stage: Decreased anagen
and increased catagen and telogen hairs are characteristic. Chronic stage: Decreased terminal and in-
creased miniaturized hairs are found with less in£ammation. Recovery: Increasing terminal anagen
hairs from regrowth of miniaturized hairs and a lack of in£ammation are noted. Conclusion: Alopecia
areata should be suspected when high percentages of telogen hairs and/or miniaturized hairs are pre-
sent, even in the absence of a peribulbar, lymphocytic in¢ltrate.
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Poster #7
The association of major histocompatibility related gene-A (MICA) and familial
alopecia areata. Nazila Barahmani, Madeleine Duvic, and Mariza de Andrade. Department of Der-
matology, University of Texas M.D. Anderson Cancer Center, Houston, TX and Department of
Health Sciences Research, Mayo Clinic, Rochester, MN.
A major histocompatibility locus (MHC) on Chromosome 6p21 encodes human leukocyte antigens
(HLA) and is a major genetic susceptibility locus for most of autoimmune diseases. MICA is one of
the members of the new MIC (MHC class I chain-related) family of genes located 46.6 kb centromeric
to HLA-B. MICA is expressed on epithelial cells in the intestine and skin, monocytes, ¢broblasts, and
endothelial cells. Case-control studies in di¡erent ethnic groups have shown associations between
HLA class I and II with Alopecia Areata (AA) patients. Our previous studies also showed a strong
association between HLA class II antigens (DQB302 and DRB4) and AA in multiplex AA families.
MICA is known to be associated with other autoimmune diseases such as psoriasis, rheumatoid arthri-
tis and Behcet’s syndrome. To further explore the association between HLA class I and AA families,
ten large multiplex AA families were studied for associated with MICA. The transmission disequili-
brium test (TDT) was applied after using polymerase chain reaction on genomic DNA samples to
distinguish between 5 known alleles. MICAwas signi¢cantly associated with AA (p¼ 0.012) and the
MICA3 allele was also associated (p¼ 0.035).We are validating these results by genotyping 80 multi-
plex families and by haplotyping 10 families. Key words: MICA (MHC class I chain related geneA)/
hair follicles/association tests/Major histocompatibility complex.
Poster #8
Do mutations in lysyl oxidase-like (LOXL) gene cause the rough coat (rc) pheno-
types in mice? Tongyu Cao, Claude Jourdan-Le Saux, Howard Passmore, Kimiko Hayashi, Masando
Hayashi, Ben Fogelgren, and Katalin Csiszar Paci¢c Biomedical Research Center, University of Ha-
waii at Manoa, Honolulu, Hawaii, U.S.A.
The rough coat (rc) mutant mice were ¢rst described at The Jackson Laboratory in 1966 as a sponta-
neous mutation. The rc mutation was inherited in a recessive mode, and homozygotes of both sexes
were fertile. A¡ected mice were born with no apparent abnormalities, but showed unkempt looking
coats by weaning age. The rc mutation was later assigned to chromosome 9, yet the gene mutation for
the rc phenotypes are yet to be identi¢ed.
One gene that has been assigned to the same region on mouse chromosome 9 is lysyl oxidase-like
protein (LOXL). LOXL was ¢rst identi¢ed through sequence homology to lysyl oxidase, a copper-
binding amine oxidase that is required for the extracellular catalysis of lysine-derived cross-links in
¢brillar collagens and elastin. The LOXL gene shares extensive homology with lysyl oxidase in the
catalytic and copper-binding domains; however, the amino-terminal half of LOXL peptide is quite
distinct from lysyl oxidase.
LOXL expression was detected at high abundance in the skin, yet the exact functions of LOXL dur-
ing development and cellular di¡erentiation of the skin are not clear. Based on the proximity of
LOXL and rc loci on mouse chromosome 9 and high LOXL expression level in the skin, we hypothe-
sized that LOXL and rc might be allelic. In this study, we carried out linkage analysis of LOXL and rc,
and examined LOXL sequence and expression in rc mice to determine whether mutations in LOXL
caused the rc phenotypes.
Poster #10
Human gene expression pro¢ling by microarray delineates disease speci¢c signa-
tures in alopecia areata. K Luettich, H King, J Xiang, J Baumgarten, AA Sinha. Department of
Dermatology,Weill Medical College of Cornell University, NY, NY
High density oligonucleotide microarrays, so called ‘‘gene chips’’, allow for simultaneous monitoring
of vast numbers of known and/or unknown sequences.We have undertaken genome wide documen-
tation of gene expression by microarray to further study the genetic basis of alopecia areata (AA).
There is clear evidence for a genetic predisposition to AA and there is increasing support for autoim-
mune activation. However, the exact mechanisms of disease initiation and progression are not well
understood. Although expression of a number of genes has been reported as altered in a¡ected scalp,
a broad perspective on the gene expression abnormalities in AA has thus far been unavailable. Total
RNAwas prepared from lesional and site-matched non-lesional scalp biopsy samples from 9 patients
with patchy, persistent AA. The RNA was then reverse transcribed and labeled using biotinylated
nucleotides, followed by hybridization to A¡ymetrix Human Genome U95A Arrays (412,500 se-
quences).We report 173 di¡erentially expressed genes between lesional and non-lesional samples: 84
up- and 89 down-regulated sequences. Hierarchical cluster analysis clearly distinguishes lesional from
non-lesional scalp. Non-hierarchical K-means clustering identi¢es 9 further sub-patterns of expres-
sion. We are currently comparing di¡erentially expressed genes in AA with other genetically based
autoimmune skin diseases such as psoriasis and vitiligo.
Poster #9
Characterization of epithelial stem cells isolated from K15/eGFP transgenic mice
using cell sorting. Yaping, Liu1; Rebecca, Morris2; Zaixin,Yang1; Carol,Trempus3; George, Cotsar-
elis1, Department of Dermatology1 University of Pennsylvania School of Medicine, Philadelphia,
Pennsylvania; Department of Dematology, Columbia University, NewYork2; Environmental Car-
cinogenesis and Mutagenesis, National Institute of Environmental Health Sciences
Kinetic and lineage studies have shown that epithelial stem cells in the hair follicle bulge di¡erentiate
into epidermis, sebaceous gland and hair follicle. Therefore, the isolation and manipulation of bulge
cells could lead to a better understanding of cellular di¡erentiation and determination in the cuta-
neous epithelium, and provide a source of stem cells for gene therapy and reconstitution of skin and
its appendages.We previously demonstrated that keratinocytes in the stem cell rich bulge area of the
hair follicle preferentially express cytokeratin 15 (K15) in both mouse and human skin.We then iso-
lated the K15 promoter and demonstrated its utility for preferentially targeting putative epithelial
stem cells in K15/lacZ transgenic mice. Here we describe the generation of transgenic mice expressing
enhanced green £uorescent protein (eGFP) under the control of the K15 promoter. Using FACS, we
isolated the brightest eGFP-positive cells from the skin of mice from 3 independent K15/eGFP lines.
The isolated cells constituted approximately 7.5% of the total live epithelial cell population.We show
that these cells have properties of epithelial stem cells. Firstly, they produce keratinocyte colonies in
vitro that are larger and more numerous when compared to non-eGFP expressing basal (alpha-6 in-
tegrin-positive) keratinocytes. Secondly, they are predominantly in the G0/G1 stage of the cell cycle
with only 0.175% of cells in S-phase, compared to 2.2% of alpha-6 integrin positive/K15-negative
cells (po0.01). Lastly, K15/eGFP-positive cells also express CD34, a marker of hematopoietic progeni-
tor cells that recently was discovered in hair follicle bulge cells. These data support the concept that
cytokeratins are expressed in a di¡erentiation-speci¢c manner, and that K15 is a marker of cutaneous
epithelial stem cells. The K15/eGFP transgenic mouse provides a valuable tool for studying epithelial
stem cell biology both in vitro and in vivo.
Poster #11
Di¡erential expression of Rho signaling molecules in the stem cell compartment
of human hair follicles. QTao, G Cotsarelis, and S Lyle. Dept. of Pathology, Beth Isreal Deacon-
ess Med. Ctr., Boston, MA and Dept. of Dermatology, Univ. of Pennsylvania, Philadelphia, PA.
We previously showed that human hair follicle stem cells reside in the hair follicle bulge, which is
delineated by keratin 15 expression. The purpose of this study was to identify genes which are speci-
¢cally expressed in the stem cell compartment of the human hair follicle so that we may better under-
stand the molecular requirements for the maintenance of the stem cell phenotype. Hair follicles were
plucked from Dispase-treated human scalp skin. Total RNA from telogen hair follicle bulges and
from anagen bulbs was labeled and hybridized to cDNA expression arrays (Clontech). Two members
of the Rho signaling pathway, RhoA and NET1 (a RhoA-speci¢c guanine exchange factor), were
present in the stem cell-enriched telogen follicle and not in the anagen bulb. Immunostaining shows
that RhoA is co-expressed in the K15 bulge area of human hair follicles at all phases of the hair cycle,
however, NET1 appears to be restricted to the bulge area at the onset of anagen. In addition, RhoA
and NET1 co-localized in clonogenic keratinocytes, cultured from telogen follicles. Therefore, RhoA
appears to be di¡erentially expressed in the keratinocyte stem cells of the human hair follicle, while
NET1 is di¡erentially and temporally expressed in the stem cell region at anagen onset when the stem
cells are activated to proliferate. Rho GTPases are small protein switches which mediate a variety of
essential cellular responses such as gene transcription, cell-cycle progression, cell adhesion and actin
reorganization. Future characterization of RhoA signaling within hair follicle stem cells should lead
a better understanding of the signaling pathways involved in stem cell maintenance.
Poster #12
LIG-1 is expressed in keratinocyte stem cells. A. Tanemura, K. Ozawa, and S. Itami Depart-
ment of Dermatology, Course of Molecular Medicine, Graduate School of Medicine, Osaka Uni-
versity, Osaka, Japan
Despite the central role of keratinocyte stem cells in tissue homeostasis, wound healing, and cancers,
the precise in vivo localization of the cells is an unsettled issue because of the lack of appropriate
molecular markers.
LIG-1 is a transmembrane glycoprotein of which the extracellular region is uniquely organized with
leucine-rich repeats and immunoglobulin-like domains.We have reported that targeted disruption of
LIG-1 gene resulted in psoriasiform epidermal hyperplasia. LIG-1 was expressed in basal cells of the
epidermis and outer root sheath cells of hair follicles in mice. The LIG-1 expression was apparently
decreased in the psoriatic lesion, suggesting that LIG-1 inversely correlates with proliferative ability of
epidermal keratinocyte. (FEBS Letters 521: 67-71, 2002). In the present study, we further examined the
expression of LIG-1 in mice and human keratinocytes in vitro. Rapidly adherent keratinocytes
(RACs) isolated from epidermis and hair follicles strongly expressed LIG-1mRNA. All of the RACs
expressed b1 integrins, and a subpopulation of the cells showed strong LIG-1 expression on their cell
surface. About 50% of the sorted cells with LIG-1 antibodies were label-retaining cells in mice skin.
LIG-1would be a new cell-surface marker for keratinocyte stem cells.
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Poster #13
Onset of alopecia areata in C3H/HeJ mice involves transient, high expression of
CD44 variant isoforms and low CD4þ/CD25þ suppressor cell activity. K.J. McEl-
wee, M. Z˛ller, P. Engel, and R. Ho¡mann. Dept. of Dermatology, Philipp University, Marburg, Ger-
many. Dept. of Tumor Progression and Tumor Defense, German Cancer Research Center, Heidelberg.
Alopecia areata (AA), a suspected autoimmune disease of anagen stage hair follicles, AA can be in-
duced in normal haired C3H/HeJ mice by grafting AA-a¡ected skin from littermates. Standard
CD44s and CD44 isoforms are adhesion molecules required for leukocyte extravasation during in-
£ammatory processes. CD4þ/CD25þ cells are known to be important for T cell homeostasis. By
£ow cytometry, we examined skin and lymph node expression levels of cytokines, CD44 variant iso-
forms, CD4, CD25, and other cell surface molecules, at 2, 6, and 12 weeks post grafting as compared
to sham grafted mice, normal haired mice and chronic AA a¡ected mice. Leukocytes in the skin of
mice 2 weeks after transplanting AA a¡ected skin highly expressed CD44v3, CD44v6, CD44v7 and
CD44v10 as compared to sham grafted control mice. By 12 weeks, expression of CD44 isoforms had
returned to normal. With chronic AA expression, CD44s and CD44v6 were slightly elevated, but
expression of CD44v3 was reduced. CD4þ/CD25þ cells were present in signi¢cantly reduced num-
bers in mice grafted with AA-a¡ected skin both at 2 weeks after grafting and in chronic AA-a¡ected
mice as compared to controls. In association, CD40 and CTLA-4 expression was reduced. Expression
of cytokines IL-2, IL-4, IL-6, IL-10 and IL-12 was elevated in mice receiving AA a¡ected skin at all
times whereas sham grafted mice exhibited only transient increases post surgery. Taken together, ex-
pression of CD44 variant isoforms appears most important for the migration of leukocytes during the
initial onset of AA, but is less signi¢cant in maintenance of the disease state that is characterized by
high cytokine production levels and an increased number of CD4þ and CD8þ cells. The low level
of CD4þ/CD25þ cells, CD40 and CTLA-4 in the skin of AA-a¡ected mice are in support of AA as
an autoimmune disease on the basis of an altered regulation of immune cell homeostasis.
Poster #14
Children with alopecia areata ^ analysis of clinical experience. Berna K. Remzi MD,
Wilma F. Bergfeld MD. Department of Dermatology,The Cleveland Clinic Foundation
Alopecia Areata is characterized with a non-scaring hair loss which a¡ects children and adults of both
gender.We aimed to analyze and assess available treatment options for children with alopecia areata
while the search of etiology and pathophysiology is continuing.We reviewed 41 patients who had an
onset of alopecia areata before 16 years of age. Patients were divided into two groups: Group I (20
patients) had alopecia areata with no known associated autoimmune diseases. Group II (21 patients)
had alopecia areata with at least one associated disease such as atopy, Hashimoto’s thyroiditis, etc. De-
mographic, disease and treatment related data were collected and severity of alopecia areata (with
photographs) was classi¢ed according to the National Alopecia Areata Foundation’s investigational
assessment guidelines. Of the 41 patients, 24 (59%) were female and 17 (41%) were male with mean
age of onset 8 (74.2) years. 31 (76%) of 41 patients had a positive family history of alopecia areata. 19
(46%) patients had baseline scalp hair loss severity ofZS3. 16 (39%) of 41 patients experienced cosme-
tically acceptable response to various treatment combinations. 8 (50%) of 16 patients, who had cosme-
tically acceptable response to treatments, had baseline scalp alopecia severity of ZS3. 9 (56%) of 16
patients had at least one associated disease such as atopy and/or thyroid dysfunction. Atopy as an asso-
ciated disease was found not signi¢cant for severity of scalp alopecia areata.
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Poster #15
Stimulation of CD8 cell apoptosis through p75 kD neurotrophin receptor as a new
approach for alopecia areata treatment. A.A. Sharov1, T.N. Palkina1,2, M. Yaar1, P. Freysch-
midt-Paul3, W. Syska4, A.Y. Baryshnikov2, R. Ho¡man3, M. Maurer4, J.P. Sundberg5, B.A. Gilchrest1,
and V.A. Botchkarev1. Depts. of Dermatology, 1Boston University School of Medicine, Boston,
MA, 3University of Marburg, Germany, 4University of Mainz, Germany, 2Cancer Research Center,
Moscow, Russia, 5Jackson Laboratory, Bar-Harbor, ME.
Neurotrophins ful¢ll a variety of non-neurotrophic functions in postnatal skin including stimulation
of murine hair follicle regression (catagen) and keratinocyte apoptosis via p75 kD neurotrophin recep-
tor (p75NTR). Here, we investigated a possible role of neurotrophins in autoimmune hair loss (alo-
pecia areata, AA). In the C3H/HeJ mouse model for AA, we showed by ELISA that brain-derived
neurotrophic factor (BDNF) and neurotrophin-4 are upregulated (po0.05) in a¡ected skin, compared
to una¡ected control. BDNF and NT-4 immunoreactivity was found in MOMA-2 positive macro-
phages of perifollicular in£ammatory in¢ltrates, while p75NTR expression was seen on CD8 lym-
phocytes. By FACS analysis, 45-75% of CD8 cells isolated from the skin and peripheral blood of
mice a¡ected byAA expressed p75NTR, while no p75NTRwas seen on CD4 cells and macrophages.
p75NTR message was detected in isolated CD8 cells using semi-quantitative RT-PCR. BDNF in-
duced apoptosis in CD8 cells isolated from the skin and peripheral blood of AA-a¡ected mice and
cultured in vitro. BDNF administration into AA-a¡ected skin was associated with hair regrowth ac-
companied by the reduction (po0.01) in number of CD8 cells, which co-expressed p75NTR and
TUNEL. Conversely, treatment of AA-a¡ected mice with cyclic peptide that blocks signaling
through p75NTR markedly increased a number of CD8 cells in skin. These data suggest a previously
unrecognized role for neurotrophins in eliminating auto-reactive CD8 cells from skin a¡ected byAA
via stimulating CD8 cell apoptosis. Stimulation of neurotrophin signaling through p75NTR may
prove a new approach for treatment of autoimmune hair loss.
Poster #16
E¡ect of Aldara 5% cream on anagen:telogen and terminal: vellus ratios in exten-
sive alopecia areata. LP Steiner, CM Boeck, ME Ericson, MJ Deeths, DAWhiting, MK Hor-
dinsky. Departments of Dermatology, University of Minnesota, University of Colorado and
University of Texas Southwestern and Baylor Hair Research and Treatment Center.
Eleven Caucasian patients with extensive long-standing alopecia areata (495% scalp hair loss, 5M, 7F,
ages 30 to 68, average disease duration 14 years) applied one packet of Aldara 5% cream to the right
half of the scalp for six months. Two 4-mm punch biopsy specimens were taken from the right par-
ietal scalp before and after treatment. Scalp biopsy specimens were vertically and horizontally sec-
tioned and stained using standard techniques. Biopsy sections were analyzed by a dermatopathologist
(DW) who was blinded to any patient information. Observations were made for the upper follicle
(infundibulum and isthmus above arrector pili muscle insertion) and lower follicle (below arrector
pili muscle insertion and including the hair bulb) on each patient’s pre- and post- treatment biopsy
specimens. After six months of Aldara 5% cream treatment, we found:
anagen:telogen ratios increased in 7/11 patients.
terminal:vellus ratios increased in 9/11 patients.
follicular structures per mm2 increased in 5/11, remained unchanged in 5/11 and decreased in one
patient.
Aldara 5% cream is known to indirectly augment interleukin-2 production and enhance Th1 re-
sponses. This drug e¡ect appears to in£uence the hair cycle. Although no patient in this study had
signi¢cant clinical improvement, Aldara 5% cream treatment did impact the hair cycle, as 5/11 patients
demonstrated increased numbers of anagen follicles. Our results demonstrate a probable correlation
between histologic improvement and cytokine production with the use of 5% Aldara cream in pa-
tients with extensive long-standing alopecia areata.
Poster #17
Cytokine pro¢les in animal models of alopecia areata. L. Tang, L. Cao, J. P. Sundberg, H.
Lui and J. Shapiro Division of Dermatology, The University of British Columbia and Vancouver
General Hospital, The Jackson Laboratory, ME
An imbalance between pro-in£ammatory cytokines and cytokine antagonists or inhibitors has been
one of the factors predisposing to initiation or perpetuation of various in£ammatory and autoimmune
disorders. Alopecia areata (AA) is a common in£ammatory disease targeting anagen hair follicles.
There are two well-known AA animal models: C3H/HeJ mice and Dundee experimental bald rat
(DEBR).The cytokine pro¢le of AA has not been extensively investigated in these AA models. Using
real time kinetic reverse transcription polymerase chain reaction and RNase protection assay, we com-
pared the cytokine expression pro¢le between normal mice and AA-a¡ected C3H/HeJ mice, between
normal Wistar rats and AA-a¡ected DEBR rats. Proin£ammatory cytokines like interferon-gamma
(IFN-g), tumor necrosis factor-a/b (TNF-a/b), and interleukin-12 (IL-12) are dramatically increased
in the AA mice. No signi¢cant changes were observed in the expression of IL-1a/b and IL-10. Inter-
estingly, the expression of TNF-a/b, IL-12 and IFN-g were consistently and signi¢cantly decreased
upon successful treatment with topical mechlorethamine in AA-a¡ected C3H/HeJ mice. In AA-af-
fected DEBR rats, increased expression of IL-1a/b,TNF-a, IFN-g was observed as compared to nor-
mal Wistar rats. The expression of TNF-a and IFN-g was down regulated on the treated sides in
DEBR rats after therapeutic hair restoration with topical anthralin treatment. In contrast, IL-10 and
IL-1 receptor antagonist (IL-1Ra) were consistently up regulated upon successful treatment in DEBR
rats. Our data illustrate that various cytokines are involved in the in£ammatory and destructive
changes during the development of AA as well as in reversing hair follicle activity during therapy. It
is likely that targeted cytokine intervention may be bene¢cial for AA.
Poster #18
Mechlorethamine-treated alopecia areata mice as a model system to study thera-
peutic mechanisms for restoring autoimmune-arrested hair follicle activity. L. Tang,
L. Cao, O. Bernado, J. P. Sundberg, H. Lui, and J. Shapiro
(AA) is an autoimmune disease targeted at hair follicles with in¢ltrative T lymphocytes likely playing
an important role in its pathogenesis. It was reported in 1985 that mechlorethamine was e¡ective on
AA patients. This has never been con¢rmed. The aims of the study were to investigate the e¡ects of
mechlorethamine on C3H/HeJ mice a¡ected byAA and to explore the underlying mechanisms. Mice
were treated on half of the dorsal skin with mechlorethamine and the contralateral side with the ve-
hicle ointment. A full pelage of hair covered the treated side in all the mice and was maintained dur-
ing the experiment, while the vehicle-treated sides showed either no change or continued hair loss.
Immunohistochemistry revealed that in¢ltrative CD4þ and CD8þ lymphocytes were eliminated
from the treated side. Furthermore, in vitro cell viability assay showed that lymphocytes were much
more sensitive to the cytotoxic e¡ects of mechlorethamine than other native skin and hair follicular
cells. Our ¢ndings support that mechlorethamine restores follicular activity by selectively targeting
in¢ltrated lymphocytes in vivo in AA-a¡ected mice.To further explore the possible molecular mechan-
isms, RNA and proteins were extracted from both treated and control skins. RNase protection assay
showed that interleukin-12, tumor necrosis factor-a/b, and interferon-g were consistently and signi¢-
cantly inhibited by mechlorethamine upon successful treatment. Protein kinase screening revealed
that growth factor mediated signaling pathway involving Erk1/2, Raf, Mek 1/2, p70S6K and p90S6K,
as well as cell cycle kinases (CDK4/5/6/7) all showed increased expression of the treated side. Another
pathway mediated by PKB and GSK-3 kinases was also up regulated. In contrast, the cell adhesion
mediated FAK kinase was dramatically inhibited by the treatment.We conclude that the molecular
mechanism underlying the e⁄cacy of mechlorethamine on hair regrowth in AA mice might be
mediated by the interplay of cytokines produced locally in the skin. The signal transduction pathways
involving various protein kinases and their regulators may represent the initial molecular events in
mouse skin upon successful mechlorethamine treatment.
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Poster #19
Clobetasol propionate 0.025% under occlusion in the treatment of alopecia totalis
and universalis. Antonella Tosti, Bianca Maria Piraccini, Massimiliano Pazzaglia, Colombina Vin-
cenzi Department of Dermatology ^ University of Bologna
We report here the results of a controlled study using clobetasol propionate 0.025% ointment under
occlusion in 28 adult patients with AT or AT/AU. All patients, after giving their informed consent to
participate in the study, were prescribed clobetasol propionate 0.025% ointment and instructed to ap-
ply 2.5 gr of the ointment to the right side of the scalp every night under occlusion with a plastic ¢lm.
The controlateral side of the scalp was left untreated as control. Patients were instructed to wash the
scalp in the morning with a mild shampoo. Treatment was performed daily for 6 days a week for 6
months.When regrowth of terminal hair occurred on the treated side, treatment was extended over
the entire scalp maintaining the same total dose (2.5 gr/day). All patients were followed up for a
further 6 months, but clobetasol propionate treatment was prolonged with the same regimen only
in responders.
Of the 28 patients included in the study, 8 were treated successfully (28.5%). Six of these were females
and 2 males. Regrowth of terminal hair started on the treated side 6 to 14 weeks after start of treat-
ment. Extension of treatment to the controlateral scalp produced complete or almost complete (95%)
hair regrowth in all of them. Three of these 8 patients however had a relapse and were not able to
maintain hair regrowth despite treatment. Our study shows that clobetasol propionate under occlu-
sion is e¡ective in inducing hair regrowth in patients with AT/AU. Although spontaneous regrowth
should always be considered when evaluating treatments of alopecia areata, the occurrence of hair re-
growth only on the treated side of the scalp con¢rms the e¡ect of the treatment. Occurrence of hair
regrowth only on the treated half of the scalp clearly shows that e⁄cacy of treatment is due to a local
and not systemic e¡ect of the drug.
Poster #20
Treatment of alopecia areata in the DEBR model using Cyclosporin A lipid vesi-
cles. D.D. Verma, S. Verma, K.J. McElweey, P. Freyschmidt-Pauly, R. Ho¡manny, and A. Fahr.
Inst. of Pharm. Tech. & Biopharm, yDept. of Dermatol., Philipp University, Marburg, Germany.
Alopecia areata (AA) is a suspected autoimmune cutaneous disease. Cyclosporin A (CyA), a T cell-
speci¢c immunosuppressant, has proven successful for the treatment of AA orally, but the bene¢cial
e¡ect of topical application is limited. However, a topical formulation is desirable given the potential
toxicity of systemically applied CyA. Topical liposome formulations have attracted considerable inter-
est concerning their potential utility both as a drug carrier and reservoir for the controlled release of
drugs within the skin and especially to the hair follicle.We evaluated the e⁄cacy of CyA in a topically
applied liposomal formulation (75%4 phosphatidylcholine, 5% lysophosphatidylcholine, 5%4 ster-
ol, natural oils) of 10% wt. in ethanol with and without 2% wt. terpenes (d-limonene: citral: ci-
neole:4 10:45:45) as a penetration enhancer using the Dundee Experimental Bald Rat (DEBR)
model. Fifteen DEBRwere allocated to 3 groups of 5. Groups I, II and III received CyAvesicles with
PE, CyA vesicles without penetration enhancer, and CyA in ethanol respectively. All rats were treated
twice a day for 6 weeks within a 2 2 cm area on one bald £ank with 20 ml/cm2 on days 0-6, 40 ml/
cm2 on days 8-14, 50 ml/cm2 on days 15-20 and 80 ml/cm2 on days 21-42 of 5 mg/ml CyA. The con-
tralateral £ank was treated with the equivalent control formulation. All 5 rats in group I showed visi-
ble hair regrowth on the drug treated site by day 7 of drug application while in group II all rats had
visible hair regrowth by day 14. The hair growth was progressive and reached a maximum density at
the site of application by day 42 in both groups. Histological examination revealed a reduced number
of in£ammatory in¢ltrate cells within the drug treated area as compared to the contralateral drug
vehicle treated £ank skin. Group III rats showed no visible signs of hair growth nor diminution of
hair follicle in£ammation. Topical CyA in a liposomal formulation had a localized hair growth pro-
moting e¡ect in DEBR suggesting that liposomes have signi¢cantly greater drug delivery capability
and increase CyA potency as compared to CyA in ethanol. The accelerated hair growth response in
group I rats suggest that penetration enhancer used in this formulation may also play a role in CyA
delivery. CyA in lipid vesicles may have signi¢cant potential for the treatment of human AA.
Poster #21
Inducible nitric oxide synthase inhibitors have no signi¢cant e¡ect on alopecia
areata in C3H/HeJ mice. K.J. McElwee, P. Freyschmidt-Paul, E.Wenzel, and R. Ho¡mann. Dept.
of Dermatology, Philipp University, Marburg, Germany.
Nitric oxide (NO) production can be an important part of in£ammation driven diseases. NO can
enhance in£ammation through vasodilation and is a cytotoxic molecule potentially involved in target
cell disruption. It is a membrane permeable gas derived from L-arginine conversion to citrulline by a
family of isoenzymes, the nitric oxide synthases (NOS). Inducible NOS (iNOS) production from
macrophages, Langerhan’s cells, granulocytes, and Th1 type CD4þ lymphocytes can be promoted by
proin£ammatory cytokines such as IL-1, TNFa and IFNg. By immunohistology, iNOS is highly
expressed in association with in£ammatory alopecia areata (AA) a¡ected hair follicles of C3H/HeJ
mice. Pentoxifylline (PTX) has been used in autoimmune disease models to inhibit iNOS as well as
modulate proin£ammatory cytokines TNFa and IFNg. Similarly, S-methyl-isothiourea (SMT) is a
selective iNOS inhibitor. PTX and SMT were injected intraperitoneally at 50mg/kg/day/mouse and
20mg/kg/day/mouse respectively, three times per week for ten weeks into 2 age matched groups of 7
AA a¡ected mice. A third group of 7 matched mice received the 0.1 ml/day/mouse PBS vehicle alone.
The high doses used failed to produce any notable hair growth e¡ect by comparison of photographic
images taken at initiation and completion of the study. Histology of treated mice also indicated no
apparent changes in hair follicle in£ammation as compared to the control group. In conclusion, iNOS
inhibitors PTX and SMT had no signi¢cant e¡ect on AA. However, given high iNOS expression in
AA foci, iNOS modulators may yet have a role as part of a multi drug therapy for AA.
Poster #22
Successful treatment of alopecia areata (AA) with diphencyprone (DPCP): analysis
of in£ammatory cells in the scalp and peripheral blood, dendritic cell (DC) func-
tion and DPCP-speci¢c proliferation of peripheral blood leukocytes (PBL) Rudolf
E. Schopf, AndreaTˇttenberg,Vanessa L˛tzsch, Ester von Stebut Dept. Dermatology, Johannes Guten-
berg Univ., Mainz, Germany
Diphencyprone treatment has the highest success rate in AA. The mechanism of action, however, is
not clear. In order to better understand the bene¢cial e¡ects of DPCP we examined the cellular in-
¢ltrate (CD3, CD4, CD25, CD45RO, CD1a, HLA-DR, ICAM-1) in the scalp in 8 patients before and
after treatment. Moreover, we also phenotyped PBL (CD2, CD14, CD19, CD3, CD4, CD8, CD56,
HLA-DR) in 3 patients successfully treated compared to healthy controls; in these individuals we also
tested the proliferation of PBL to DPCP and the capacity of mature DCs generated from PBL to
stimulate allogeneic CD4þ and CD8þ cells. In the dermis CD1aþ and CD25þ cells signi¢cantly
decreased while CD8þ cells increased after successful treatment (po0.025,Wilcoxon test). Compared
to healthy controls AA patients after treatment exhibited 2-3 times more CD14þ , CD19þ, CD56þ
and HLA-DRþ cells among PBLs. PBLs also showed increased proliferation to DPCP compared to
untreated donors; the response to the recall antigens tetanus toxoid and PPD was unchanged. Mature
DCs generated from PBLs of AA patients showed normal allostimulatory capacity.We conclude that
successful treatment of AAwith DPCP is associated with a down regulation of the number of acti-
vated Tcells and antigen-presenting CD1aþ cells as well as an increase in CD8þ cells in the scalp. In
the blood there is an increased percentage of monocytes, B cells, NK cells and HLA-DRþ cells as
well as a capacity of PBLs to proliferate to stimulation with DPCP that is not due to altered function
of antigen-presenting dendritic cells.
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Poster #23
Attitudes and perceptions of school-aged children toward alopecia areata. Heidi
McMillan,1 Marshall Jones,2 Je¡rey Miller,3 1Department of Pediatrics, Hershey Medical Center, DA,
Hershey, PA, U.S.A. 2Department of Behavioral Science, Hershey Medical Center, Hershey, PA,
U.S.A. 3Department of Dermatology, Hershey Medical Center, Hershey, PA, USA
Alopecia areata (AA) is a psychologically devastating medical condition. This study examined the at-
titudes and perceptions of school-aged children (kindergarten [K] ^ 8th grade) to AA. Subjects were
shown a photo of a child with AA and asked a series of questions relating to hair loss. Younger chil-
dren (K-3rd grade) were more likely to display visible discomfort when viewing a photo of a child
with AA compared to older children (5th ^8th grade). Younger children (K-2nd grade) more often
believe a child with AA is very sick and contagious compared to older children (4th-8th grade).Young-
er children (K-3rd grade) were more likely to be afraid to get close to a child with AA compared to
older children (5th-8th grade). The concept of cancer as a cause of hair loss emerges in 3rd-8th grade
children. Children across all grade levels demonstrate feelings of sadness and want to know ‘‘what
happened.’’ Children’s perception of hair loss representative of AA changes markedly across grade le-
vels. Knowledge of the di¡ering perceptions is helpful in counseling and educating a child with new
onset AA.
Oral Presentation on Saturday morning
Poster #24
Psychological distress: A pro¢le of alopecia areata patients. Sandy Venneman1,2, Elaine
Siegfried3, John Cross 1Department of Psychology, St. Louis University; 2Departments of Psychol-
ogy and Biology, University of Houston-Victoria; 3School of Medicine, St. Louis University, St.
Louis, Missouri, USA
Stress has been popularized as a common cause of hair loss.While physical and psychological stressors
are accepted as precursors to telogen e¥uvium, the association has not been clari¢ed for AA. Genetic
factors, rather than stress, are assumed to be the primary cause of AGA and linked to AA.We exam-
ined indicators of stress in AA and AGA subjects seeking medical evaluation or treatment for hair loss.
Patients,(N¼ 46) completed questionnaires that included measures of stress, stress correlates and per-
sonality factors. Data from these factors were statistically analyzed in a discriminate function analysis
with the following results; males with AA and AGA had comparable scores for all variables, including
signi¢cant depression; females with AA exhibited anxiety, while those with AGA exhibited depres-
sion and low Positive A¡ect. The results do not support a causal role of stress in AA, but do emphasize
that anxiety and/or depression are a common co-morbidity for patients with hair loss. This suggests
that medical personnel recommend the possibility of psychological assistance for hair loss patients
through psychological/psychiatric avenues and/or support groups.
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